RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence

NCT ID: NCT01409421

Last Updated: 2015-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

201 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are studying motivational interviewing (MI). MI is a counseling method to help people adopt healthy behaviors. The investigators will test whether MI improves patients' accurate use of glaucoma eye drops. The investigators will train eye clinic staff called glaucoma educators to use MI. Up to 250 patients at 3 clinics will be recruited. All patients will receive their usual eye care. Based on chance, some patients will also be supported by a glaucoma educator. The groups will be compared on medication adherence using micro-electro-mechanical system(MEMS). MEMS are electronic bottle caps that track when a medication bottle is opened. Patients will be aware that their medication use is tracked. The groups will also be compared on treatment value, outcomes, and cost. The investigators will also collect data on variables that may predict medication adherence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Open Angle Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

motivational interviewing

3 phone and 3 in person counseling support sessions with glaucoma educator

Group Type EXPERIMENTAL

motivational interviewing

Intervention Type BEHAVIORAL

counseling intervention

reminder calls

behavioral: three phone calls to remind patients to take their eye drops

Group Type ACTIVE_COMPARATOR

three phone calls to remind patients to take their eye drops

Intervention Type BEHAVIORAL

reminder phone calls

standard care

standard care for glaucoma

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

motivational interviewing

counseling intervention

Intervention Type BEHAVIORAL

three phone calls to remind patients to take their eye drops

reminder phone calls

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* community-dwelling adults with primary or secondary open-angle glaucoma, and
* a current prescription for monotherapy topical glaucoma medication.

Exclusion Criteria

* patient-reported inability to administer eye drops that cannot be addressed successfully through in-person instruction at the clinic,
* cognitive impairment at a level that would in the judgment of the referring physician interfere with study participation,
* referring physician's determination that glaucoma surgery is likely within the next 6 months,
* any active medical, psychological, or substance use disorder that would in the referring physician's judgment significantly interfere with study participation (e.g., comorbid congestive heart failure (CHF) resulting in a recent hospitalization; active psychosis due to uncontrolled bipolar disorder; etc.), or
* no visual field test within the past 6 months (data required for the randomization approach described below).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role collaborator

University of Colorado, Denver

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Malik Kahook, MD

Role: PRINCIPAL_INVESTIGATOR

Lions Eye Inst. UC Denver

Paul F Cook, Ph.D

Role: PRINCIPAL_INVESTIGATOR

UC Denver, College of Nursing

Jeffery Kammer, MD

Role: PRINCIPAL_INVESTIGATOR

Vanderbilt University- Opthamology

Steve Mansberger, MD

Role: PRINCIPAL_INVESTIGATOR

Devers Eye Inst. Oregon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lions Eye Institute, UC Denver

Aurora, Colorado, United States

Site Status

Devers Eye Institute

Portland, Oregon, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Cook PF, Schmiege SJ, Mansberger SL, Kammer J, Fitzgerald T, Kahook MY. Predictors of adherence to glaucoma treatment in a multisite study. Ann Behav Med. 2015 Feb;49(1):29-39. doi: 10.1007/s12160-014-9641-8.

Reference Type DERIVED
PMID: 25248302 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2517807

Identifier Type: OTHER

Identifier Source: secondary_id

11-0122

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.